Ribonucleotide reductase subunit-2 (RRM2) and thymidylate synthase (TS) to predict shorter survival in patients (pts) with resected stage I-III non-small cell lung cancer (NSCLC).
Francesco Grossi
No relevant relationships to disclose
Maria Giovanna Dal Bello
No relevant relationships to disclose
Graziana Savarino
No relevant relationships to disclose
Sandra Salvi
No relevant relationships to disclose
Roberto Puzone
No relevant relationships to disclose
Ulrich Pfeffer
No relevant relationships to disclose
Vincenzo Fontana
No relevant relationships to disclose
Erika Rijavec
No relevant relationships to disclose
Giulia Barletta
No relevant relationships to disclose
Carlo Genova
No relevant relationships to disclose
Claudio Sini
No relevant relationships to disclose
Giovanni Battista Ratto
No relevant relationships to disclose
Mauro Truini
No relevant relationships to disclose
Domenico Franco Merlo
No relevant relationships to disclose